Novartis | NVS - Активы

Биржевая цена
146.73
Изменение за день
-1.25 -0.84%
Ежемесячно
-4.69%
Ежегодный
28.34%
Q2 прогноз
142.62




Активы Изменить Дата
AbbVie USD 133.96B 62M 2025-12
Amgen USD 92.5B 1.92B 2026-03
AstraZeneca USD 114.02B 59M 2026-03
Bausch Health Companies USD 24.5B 1.87B 2026-03
Biogen USD 29.48B 43.6M 2026-03
Bristol-Myers Squibb USD 86.48B 3.56B 2026-03
Canopy Growth CAD 1.11B 36.35M 2025-12
Corcept Therapeutics USD 814.88M 21.77M 2026-03
Drreddys Laboratories INR 6.26B 161.9M 2025-12
Eli Lilly USD 116.58B 4.1B 2026-03
Gilead Sciences USD 59.02B 490M 2025-12
GlaxoSmithKline GBP 62.87B 1.75B 2026-03
Glaxosmithkline GBP 82.34B 102.25M 2025-12
J&J USD 200.89B 1.68B 2026-03
Merck USD 136.87B 7.32B 2025-12
Novartis USD 110.95B 3.66B 2025-12
Novartis USD 110.95B 3.66B 2025-12
Pacira USD 1.21B 56.38M 2026-03
Perrigo USD 8.54B 1.55B 2025-12
Pfizer USD 208.73B 2.64B 2025-09
Phibro Animal Health USD 1.41B 20.03M 2025-12
Prestige Brands USD 3.49B 52.46M 2025-12
Roche Holding CHF 100.7B 5.94B 2025-12
Sanofi EUR 128.02B 1.22B 2026-03
Sanofi EUR 126.81B 25.48B 2025-12
Supernus Pharmaceuticals USD 1.45B 32.89M 2025-12
Zoetis USD 15.47B 308M 2025-12